4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-23-062812
Options or other derivatives
- Director acquired 45,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Calais Philippe Director | 2023-05-19 | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | D | ||
Loading xslF345X04/tm2316383-1_4seq1.xml…